Alx Oncology Holdings Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Lettmann Jason acquired Company’s shares for reported $76892.0 on Sep 17 ’25. In the deal valued at $1.08 per share,71,163 shares were bought. As a result of this transaction, Lettmann Jason now holds 305,121 shares worth roughly $0.67 million.
Then, Lettmann Jason bought 21,070 shares, generating $22,461 in total proceeds. Upon buying the shares at $1.07, the CHIEF EXECUTIVE OFFICER now owns 233,958 shares.
Before that, Shantharam Harish bought 75,000 shares. Alx Oncology Holdings Inc shares valued at $58,402 were divested by the Chief Financial Officer at a price of $0.78 per share. As a result of the transaction, Shantharam Harish now holds 75,000 shares, worth roughly $0.16 million.
Jefferies upgraded its Alx Oncology Holdings Inc [ALXO] rating to a Buy from a a Hold in a research note published on March 06, 2025; the price target was increased to $3 from $2. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid December from “a Buy” to “a Hold”. Stifel also remained covering ALXO and has decreased its forecast on March 08, 2024 with a “Hold” recommendation from previously “Buy” rating. Jefferies revised its rating on December 08, 2023. It rated ALXO as “a Buy” which previously was an “a Hold”.
Price Performance Review of ALXO
On Friday, Alx Oncology Holdings Inc [NASDAQ:ALXO] saw its stock jump 14.14% to $2.18. Over the last five days, the stock has gained 16.58%. Alx Oncology Holdings Inc shares have risen nearly 17.20% since the year began. Nevertheless, the stocks have risen 30.54% over the past one year. While a 52-week high of $2.05 was reached on 10/03/25, a 52-week low of $0.40 was recorded on 06/27/25.
Levels Of Support And Resistance For ALXO Stock
The 24-hour chart illustrates a support level at 1.98, which if violated will result in even more drops to 1.77. On the upside, there is a resistance level at 2.31. A further resistance level may holdings at 2.44.
How much short interest is there in Alx Oncology Holdings Inc?
A steep rise in short interest was recorded in Alx Oncology Holdings Inc stocks on 2025-09-15, dropping by 54750.0 shares to a total of 1.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 1.63 million shares. There was a decline of -3.47%, which implies that there is a negative sentiment for the stock.
